Pharmacy News

Researchers tease out benefit of HPV vaccine based on dose and age group

Findings from a new population-based study found that no matter how many doses of bivalent HPV vaccine were administered, no woman who received the HPV bivalent vaccine at age 12 or 13 years developed invasive cancer later.

CDC seeks to expand University of Michigan’s pharmacist hypertension program across U.S.

According to CDC's recent assessment of the University of Michigan’s Hypertension Pharmacists’ Program (HPP), 66% of patients who consulted with an HPP pharmacist brought their disease under control within 3 months compared with 42% of patients who did not meet with a pharmacist. At 6 months, 69% had their BP under control compared with 56% of nonparticipants.

Low-dose aspirin during pregnancy appears to have no effect on child’s neurodevelopment

Low-dose aspirin during pregnancy is safe, according to a new study published in The American College of Obstetricians and Gynecologists’ Obstetrics and Gynecology. Researchers found that the Bayley Scales of Infant and Toddler Development (Bayley-III) cognitive composite scores indicated no difference when pregnant parents took low-dose aspirin early in pregnancy compared to a placebo. In other words, it neither worsened nor improved a child’s neurodevelopment.

BP improves with patients taking GLP-1, says study

Results from a new study published in the American Heart Association’s Hypertension showed that the GLP-1, tirzepatide, reduced 24-hour systolic BP, both at night and in the daytime compared with placebo.

Why are cases of syphilis soaring?

CDC stated that the United States is seeing the highest incidence of syphilis since 1950. In its new report, the agency maps out an astonishing comeback for a disease that had previously reached near-eradication status.